What Researchers Did
Researchers looked back at medical records of 240 patients treated for carbon monoxide poisoning over 10 years in four hospitals to find out what factors might predict if they would develop delayed neurological syndrome.
What They Found
Out of 240 carbon monoxide poisoning cases, 44 patients had follow-up information, and 11 of these (25%) developed delayed neurological syndrome. The study found that a low score on the initial Glasgow Coma Scale, which measures a person's consciousness, was a strong predictor for developing this syndrome (P .001).
What This Means for Canadian Patients
For Canadian patients who have experienced carbon monoxide poisoning, this study suggests that those with a low Glasgow Coma Scale score upon hospital admission may be at higher risk for delayed neurological syndrome. Recognizing this risk factor could help doctors identify patients who might benefit from closer monitoring and timely intervention, including hyperbaric oxygen therapy if appropriate, to manage potential long-term neurological issues.
Canadian Relevance
This study was not conducted in Canada, but it covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A significant limitation of this retrospective study is that follow-up information was only available for a small percentage (18.3%) of the identified patients, which may affect the generalizability of the findings.